drugset / Trial / NCT01582321

Investigation of the Influence of Gender on Cardiovascular Function

NCT01582321

Phase 0 Completed 56 enrolled Queen Mary University of London
Non-randomizedParallel-groupOpen-labelBasic science

Summary

Inflammation is a key initiating and damaging factor in many illnesses including infection, arthritis and cancer but also of particular relevance to this study in diseases of the heart and blood vessels (i.e. cardiovascular disease). Much evidence now exists demonstrating that male sex increases ones risk of cardiovascular disease. More recent evidence demonstrates that inflammatory responses in females appear to dampened in comparison to age matched males. Since inflammation is thought to be a key initiating phenomenon in many cardiovascular disease states the investigators will examine the differences in acute inflammatory responses between the sexes in healthy volunteers and the impact this has on the function of blood vessels.

Timeline

Start
2012-03
Primary completion
2016-12
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Background Cantharidin Small molecule 0.01 ml Topical
Background Typhoid Vaccine Vaccine 25 ug Intramuscular

Indications

No indication recorded.